BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16166337)

  • 21. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
    Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
    Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
    Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.
    Laezza C; Malfitano AM; Di Matola T; Ricchi P; Bifulco M
    Mol Carcinog; 2010 Oct; 49(10):892-901. PubMed ID: 20672320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
    Singh S; Bhat MK
    Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.
    Bardon S; Picard K; Martel P
    Nutr Cancer; 1998; 32(1):1-7. PubMed ID: 9824849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
    Strauss SJ; Higginbottom K; Jüliger S; Maharaj L; Allen P; Schenkein D; Lister TA; Joel SP
    Cancer Res; 2007 Mar; 67(6):2783-90. PubMed ID: 17363600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of perillyl alcohol in pancreatic cancer.
    Matos JM; Schmidt CM; Thomas HJ; Cummings OW; Wiebke EA; Madura JA; Patrick LJ; Crowell PL
    J Surg Res; 2008 Jun; 147(2):194-9. PubMed ID: 18498869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects.
    Xu M; Floyd HS; Greth SM; Chang WC; Lohman K; Stoyanova R; Kucera GL; Kute TE; Willingham MC; Miller MS
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):232-46. PubMed ID: 14998688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.
    Yousefi M; Ghaffari SH; Zekri A; Hassani S; Alimoghaddam K; Ghavamzadeh A
    Arch Iran Med; 2014 May; 17(5):366-71. PubMed ID: 24784867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of NF-kappaB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines.
    Berger N; Ben Bassat H; Klein BY; Laskov R
    Exp Hematol; 2007 Oct; 35(10):1495-509. PubMed ID: 17889719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling.
    Hassan SB; Gali-Muhtasib H; Göransson H; Larsson R
    Anticancer Res; 2010 Jun; 30(6):1911-9. PubMed ID: 20651334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
    Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
    Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
    Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
    Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
    Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
    Wu M; Lee H; Bellas RE; Schauer SL; Arsura M; Katz D; FitzGerald MJ; Rothstein TL; Sherr DH; Sonenshein GE
    EMBO J; 1996 Sep; 15(17):4682-90. PubMed ID: 8887559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
    Monks NR; Pardee AB
    J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.